1. Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study.
- Author
-
Matsuo Y, Jo T, Watanabe H, Matsui H, Fushimi K, and Yasunaga H
- Subjects
- Humans, Retrospective Studies, Female, Male, Middle Aged, Aged, Japan, Adrenergic beta-1 Receptor Antagonists therapeutic use, Adrenergic beta-Antagonists therapeutic use, Adult, Propensity Score, Propranolol therapeutic use, Thyroid Crisis drug therapy, Thyroid Crisis mortality, Hospital Mortality
- Abstract
Objectives: Thyroid storm is the most severe manifestation of thyrotoxicosis. Beta-blockers are among the standard treatment regimens for this condition, with propranolol being the historically preferred option. However, 2016 guidelines issued by the Japan Thyroid Association and the Japan Endocrine Society recommend the use of beta-1 selective beta-blockers over nonselective beta-blockers, such as propranolol. Nevertheless, evidence supporting this recommendation is limited. Herein, we aimed to investigate the in-hospital mortality of patients with thyroid storms based on the choice of beta-blockers., Design: Retrospective cohort study., Setting: The Diagnosis Procedure Combination database, a national inpatient database in Japan., Patients: Patients hospitalized with thyroid storm between April 2010 and March 2022., Interventions: Propensity-score overlap weighting was performed to compare in-hospital mortality between patients who received beta-1 selective beta-blockers and those who received propranolol. Subgroup analysis was also conducted, considering the presence or absence of acute heart failure., Measurements and Main Results: Among the 2462 eligible patients, 1452 received beta-1 selective beta-blockers and 1010 received propranolol. The crude in-hospital mortality rates were 9.3% for the beta-1 selective beta-blocker group and 6.2% for the propranolol group. After adjusting for baseline variables, the use of beta-1 selective beta-blockers was not associated with lower in-hospital mortality (6.3% vs. 7.4%; odds ratio, 0.85; 95% CI, 0.57-1.26). Furthermore, no significant difference in in-hospital mortality was observed in patients with acute heart failure., Conclusions: In patients with thyroid storm, the choice between beta-1 selective beta-blockers and propranolol did not affect in-hospital mortality, regardless of the presence of acute heart failure. Therefore, both beta-1 selective beta-blockers and propranolol can be regarded as viable treatment options for beta-blocker therapy in cases of thyroid storm, contingent upon the clinical context., Competing Interests: Dr. Matsuo’s institution received funding from the Ministry of Health, Labor, and Welfare of Japan (grants 23AA2003 and 22AA2003). Dr. Matsui’s institution received funding from Japanese Kakenhi (grants 20H03907 and 21H03159). The remaining authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2024 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.)
- Published
- 2024
- Full Text
- View/download PDF